Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effects
- 1 June 1979
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 97 (6) , 797-807
- https://doi.org/10.1016/0002-8703(79)90016-4
Abstract
No abstract availableKeywords
This publication has 79 references indexed in Scilit:
- HypertensionDrugs, 1976
- Comparison of the Effects on Renin Release of Beta Adrenergic Antagonists with Differing PropertiesJournal of Clinical Investigation, 1974
- Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol, and their enantiomersCardiovascular Research, 1974
- Effect of practolol on blood pressure and renin release in manClinical Pharmacology & Therapeutics, 1974
- HEMODYNAMIC EFFECTS OF ACUTE AND PROLONGED β‐ADRENERGIC BLOCKADE IN ESSENTIAL HYPERTENSIONActa Medica Scandinavica, 1974
- -Blockers and Plasma Renin Activity in HypertensionBMJ, 1974
- Vasoconstriction-volume analysis for understanding and treating hypertension: The use of renin and aldosterone profilesThe American Journal of Medicine, 1973
- The Effect in Man of (+)-Propranolol and Racemic Propranolol on Renin Secretion Stimulated by Orthostatic StressClinical Science, 1973
- The Effect of Chronic Adrenergic Receptor Blockade on Plasma Renin Activity in ManJournal of Clinical Endocrinology & Metabolism, 1972
- Adrenergic Receptor Mediation of Renin SecretionJournal of Clinical Endocrinology & Metabolism, 1969